Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 4
2016 7
2017 4
2018 4
2019 5
2020 5
2021 1
2022 4
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.
Advani AS, Moseley A, O'Dwyer KM, Wood BL, Park J, Wieduwilt M, Jeyakumar D, Yaghmour G, Atallah EL, Gerds AT, O'Brien SM, Liesveld JL, Othus M, Litzow M, Stone RM, Sharon E, Erba HP. Advani AS, et al. Among authors: yaghmour g. Blood Adv. 2023 Apr 11;7(7):1279-1285. doi: 10.1182/bloodadvances.2022008216. Blood Adv. 2023. PMID: 36322825 Free PMC article.
Hepatitic Variant of Graft-vs-Host Disease.
Liang TZ, Dong S, Fang M, Gong Y, Yaghmour G, Chopra S. Liang TZ, et al. Among authors: yaghmour g. Am J Clin Pathol. 2022 Jun 7;157(6):948-955. doi: 10.1093/ajcp/aqab215. Am J Clin Pathol. 2022. PMID: 35038720
How Center Volumes Affect Early Outcomes in Acute Myeloid Leukemia.
Hahn AW, Jamy O, Nunnery S, Yaghmour G, Giri S, Pathak R, Martin MG. Hahn AW, et al. Among authors: yaghmour g. Clin Lymphoma Myeloma Leuk. 2015 Nov;15(11):646-54. doi: 10.1016/j.clml.2015.07.646. Epub 2015 Aug 5. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26386907 Review.
Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis.
Dwabe S, Hsiao M, Ali A, Rodman J, Savitala-Damerla L, Nazaretyan S, Kimberly Schiff NP, Tam E, Ladha A, Woan K, Chaudhary P, Yaghmour G. Dwabe S, et al. Among authors: yaghmour g. Transpl Immunol. 2023 Feb;76:101769. doi: 10.1016/j.trim.2022.101769. Epub 2022 Dec 2. Transpl Immunol. 2023. PMID: 36464218
Ibrutinib has some activity in Richter's syndrome.
Giri S, Hahn A, Yaghmour G, Martin MG. Giri S, et al. Among authors: yaghmour g. Blood Cancer J. 2015 Jan 30;5(1):e277. doi: 10.1038/bcj.2014.98. Blood Cancer J. 2015. PMID: 25635530 Free PMC article. No abstract available.
41 results